HK1113319A1 - Use of docosahexaenoic triglycerides for the treatment of tumorous diseases - Google Patents

Use of docosahexaenoic triglycerides for the treatment of tumorous diseases

Info

Publication number
HK1113319A1
HK1113319A1 HK08108365.2A HK08108365A HK1113319A1 HK 1113319 A1 HK1113319 A1 HK 1113319A1 HK 08108365 A HK08108365 A HK 08108365A HK 1113319 A1 HK1113319 A1 HK 1113319A1
Authority
HK
Hong Kong
Prior art keywords
docosahexaenoic
triglycerides
treatment
tumorous diseases
tumorous
Prior art date
Application number
HK08108365.2A
Other languages
English (en)
Chinese (zh)
Inventor
Pedrol Joan Carles Domingo
Original Assignee
Brudy Technology S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brudy Technology S L filed Critical Brudy Technology S L
Publication of HK1113319A1 publication Critical patent/HK1113319A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08108365.2A 2005-05-12 2008-07-29 Use of docosahexaenoic triglycerides for the treatment of tumorous diseases HK1113319A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200501141A ES2264886B1 (es) 2005-05-12 2005-05-12 Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
PCT/EP2006/061833 WO2006120120A1 (en) 2005-05-12 2006-04-26 Use of docosahexaenoic glycerides for the treatment of tumorous diseases

Publications (1)

Publication Number Publication Date
HK1113319A1 true HK1113319A1 (en) 2008-10-03

Family

ID=36809521

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108365.2A HK1113319A1 (en) 2005-05-12 2008-07-29 Use of docosahexaenoic triglycerides for the treatment of tumorous diseases

Country Status (13)

Country Link
US (3) US20080207947A1 (xx)
EP (1) EP1881824B1 (xx)
JP (2) JP5893235B2 (xx)
CA (1) CA2614192C (xx)
DK (1) DK1881824T3 (xx)
ES (2) ES2264886B1 (xx)
HK (1) HK1113319A1 (xx)
IL (1) IL187274A (xx)
NO (1) NO336953B1 (xx)
NZ (1) NZ563301A (xx)
PL (1) PL1881824T3 (xx)
PT (1) PT1881824E (xx)
WO (1) WO2006120120A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2264886B1 (es) * 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
CA2614473C (en) * 2005-07-08 2016-05-03 Martek Biosciences Corporation Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
MX2008008171A (es) * 2005-12-21 2008-11-12 Brudy Technology S L Uso de dha epa o epa derivado de dha para tratamiento de una patologia asociada al daño celular oxidante.
ES2277557B1 (es) 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2708679C (en) * 2007-12-19 2016-11-15 Prometic Biosciences Inc. Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
WO2011103512A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation Dha free fatty acid emulsions
US20110200644A1 (en) * 2010-02-18 2011-08-18 Martek Biosciences Corporation DHA Ester Emulsions
US20110206741A1 (en) * 2010-02-18 2011-08-25 Martek Biosciences Corporation DHA Triglyceride Emulsions
EP2599485B1 (en) * 2010-07-26 2019-02-20 FUJIFILM Corporation Fat-containing composition and oral formulation containing same
JP6495245B2 (ja) 2013-04-22 2019-04-03 スマートフィッシュ・アーエス がんの治療及び／又は後治療のための魚油及びジュースを含む組成物の使用
KR101665253B1 (ko) 2015-06-19 2016-10-25 순천향대학교 산학협력단 도코사헥사에노산 및 트리아신 씨를 포함하는 것을 특징으로 하는 자궁내막암 치료 및 예방용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
US5147854A (en) * 1990-05-22 1992-09-15 Hoffmann-La Roche Inc. Tgf-b compositions and method
JP2572692B2 (ja) * 1991-07-24 1997-01-16 ボーソー油脂 株式会社 ドコサヘキサエン酸トリグリセリドの製造法
JPH05139968A (ja) * 1991-11-14 1993-06-08 Sagami Chem Res Center メダラシン活性促進剤
JPH0616548A (ja) * 1992-06-30 1994-01-25 Sagami Chem Res Center 組織異常増殖抑制剤
JPH06116585A (ja) * 1992-10-09 1994-04-26 Kanegafuchi Chem Ind Co Ltd 油脂の精製方法
JP3526632B2 (ja) * 1994-08-22 2004-05-17 旭化成ケミカルズ株式会社 高度不飽和脂肪酸含有油脂
JPH1057086A (ja) * 1996-08-20 1998-03-03 Asahi Chem Ind Co Ltd 高濃度ドコサヘキサエン酸モノグリセリドの製造方法
EP1214067A1 (en) * 1999-09-09 2002-06-19 EFA Sciences Llc Methods for treating cell proliferative disorders including cancer
JP2002180082A (ja) * 2000-12-11 2002-06-26 Maruha Corp 摂取物
US20040052837A1 (en) * 2002-06-27 2004-03-18 William Stillwell Lipid conjugated anti-cancer drugs and methods of use thereof
ES2264886B1 (es) * 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.

Also Published As

Publication number Publication date
EP1881824A1 (en) 2008-01-30
PT1881824E (pt) 2015-03-26
NO336953B1 (no) 2015-11-30
DK1881824T3 (en) 2015-02-23
NZ563301A (en) 2010-08-27
CA2614192A1 (en) 2006-11-16
JP5893235B2 (ja) 2016-03-23
US9271954B2 (en) 2016-03-01
JP6038841B2 (ja) 2016-12-07
ES2264886A1 (es) 2007-01-16
IL187274A (en) 2011-11-30
JP2008540484A (ja) 2008-11-20
CA2614192C (en) 2014-03-18
ES2264886B1 (es) 2008-02-01
US20080207947A1 (en) 2008-08-28
NO20076382L (no) 2008-02-08
JP2014208677A (ja) 2014-11-06
IL187274A0 (en) 2008-06-05
EP1881824B1 (en) 2014-12-24
US20160193175A1 (en) 2016-07-07
US20090318553A1 (en) 2009-12-24
PL1881824T3 (pl) 2015-06-30
WO2006120120A1 (en) 2006-11-16
US20170333381A9 (en) 2017-11-23
ES2531599T3 (es) 2015-03-17

Similar Documents

Publication Publication Date Title
PT1881824E (pt) Utilização de triglicéridos docosaexaenóicos para o tratamento de doenças tumorais
HRP20150175T1 (xx) Sredstva za i postupci lijeäśenja tumorskih bolesti
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
HK1215960A1 (zh) 用於治療視網膜變性疾病的改良方式
HK1207821A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
ZA200707591B (en) Dihyrothienopyrimidines for the treatment of inflammatory diseases
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
PT2056842E (pt) Galactosil-ceramidas modificadas para coloração e estimulação de células t assassinas naturais
EP1789034A4 (en) COMPOUNDS HAVING A DIPHENYL STRUCTURE FOR THE TREATMENT OF IMMUNE DISEASES
GB0523961D0 (en) The treatment of ophthalmic diseases
SI2076268T1 (sl) Roskovitin za zdravljenje določenih cističnih bolezni
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
PL1904060T3 (pl) Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób
GB0523964D0 (en) The treatment of ophthalmic diseases
GB0519274D0 (en) The treatment of neurodegenerative diseases
ZA200606780B (en) Compounds for the treatment of diseases
EP1846013A4 (en) TREATMENT OF SKIN DISEASES
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0700755D0 (en) The Treatment of ophthalmic diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220421